Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999270 · ClinicalTrials.gov registry record · Phase 1
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
A Phase 1 study of Glioma and Ganglioneuroma, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01999270 is a Phase 1 study of Glioma and Ganglioneuroma that has completed, run by Washington University School of Medicine. The registered enrollment target is 6 participants, below the 210-participant average among 87 other Glioma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01999270, a Phase 1 study of Glioma and Ganglioneuroma, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if FDOPA-PET/MRI imaging can predict response to treatment of bevacizumab.
Conditions Studied
Interventions
- DRUG Bevacizumab
- DRUG Irinotecan
- DEVICE FDOPA-PET/MRI imaging
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01999270
The ClinicalTrials.gov registry entry for NCT01999270 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 87 other Glioma trials with a reported enrollment target (97% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Glioma appearing as the primary indexed condition, and to 3 interventions - of which Bevacizumab is the first listed.
NCT01999270 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01999270 about?
NCT01999270 is a clinical study titled "Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors". To determine if FDOPA-PET/MRI imaging can predict response to treatment of bevacizumab.
What is the current status of trial NCT01999270?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2013-04. Estimated completion is 2016-05.
What conditions does trial NCT01999270 study?
This clinical trial studies the following conditions: Glioma, Ganglioneuroma, Ganglioglioma, Astrocytoma, Oligoastrocytoma, Mixed, Glioblastoma Multiforme Glioma.
What interventions are being tested in trial NCT01999270?
The interventions under investigation include: Bevacizumab (DRUG), Irinotecan (DRUG), FDOPA-PET/MRI imaging (DEVICE).
Who is sponsoring clinical trial NCT01999270?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01999270 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
RECRUITING · Phase 1
-
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RECRUITING · Phase 1
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
A Study of 177Lu-PSMA-617 in People With Gliomas
RECRUITING · Phase 1
-
Hyperpolarized Imaging in Diagnosing Participants With Glioma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.